葛蘭素史克 GSK 深 滬
等待開盤 09-23 09:30:00 美东时间
50.72
-0.360
-0.70%
華盛通- 最 高50.99
- 今 開50.69
- 成交量 429.62万股
- 最 低 50.22
- 昨 收 51.08
- 總市值 1016.18亿
- 52周最高 60.3334
- 市盈率 靜 13.86
- 換手率 0.21%
- 52周最低 41.0578
- 委 比 -23.37%
- 總股本 20.04亿
- 歷史最高 60.3334
- 量 比 1.32
- 振 幅 1.51%
- 歷史最低 8.0856
- 每 手 1
- 風險率 4.58%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多高盛首予Tempus AI“中性”评级：诊断业务等来报销红利，数据合同却进入“验证期”
高盛给予Tempus AI“中性”评级和75美元目标价;xT与xF报销红利可期，但大药企合同和护城河持久性仍待验证。
09-22 21:12
UBS Remains a Hold on GlaxoSmithKline (GSK)
In a report released yesterday, Matthew Weston from UBS maintained a Hold ratin...
09-18 11:15
GSK Halts Key Phase 2 Alzheimer’s Trial, Resetting Investor Expectations
GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. The...
09-18 00:30
IL-5靶点，进入收获期
（来源：药研网） 2026年6月23日，葛兰素史克宣布，国家药品监督管理局已批准美泊利珠单抗注射液（新可来®）用于成人和12岁及以上青少年无明确的非血液学继发性...
09-17 11:34
葛兰素史克以高达7.5亿美元收购中国生物技术公司药物
（来源：欧洲并购与投资） 葛兰素史克以高达7.5亿美元收购中国生物技术公司药物 图片来源于网络 英国制药集团GSK近日再次加码中国创新药，与中国生...
09-16 16:13
GSK与恩沐生物达成一项价值高达7.5亿美元的癌症靶向药物交易
9月15日，财闻据路透社报道，葛兰素史克（GSK.US）已达成一项价值最高达7.5亿美元的协议，从中国生物技术公司恩沐生物购买一款三特异性T细胞衔接器（TCE...
09-15 15:21
Why Is GSK Stock Gaining Monday?
On Monday, GSK plc (NYSE:GSK) stock is trading higher on highly positive clinical data from two separate lung cancer trials, demonstrating significant efficacy and survival benefits across different patient populations. Strong Survival Rates In Small Cell Lung Cancer In partnership with licensor Han...
09-15 00:03
公司簡介
公司名稱
|
葛兰素史克
|
行業分類
|
制药
|
業務描述
|
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Commercial Operations and Total Research and Development. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in London, the United Kingdom.
|
高盛首予Tempus AI“中性”评级：诊断业务等来报销红利，数据合同却进入“验证期”
高盛给予Tempus AI“中性”评级和75美元目标价;xT与xF报销红利可期，但大药企合同和护城河持久性仍待验证。
09-22 21:12
UBS Remains a Hold on GlaxoSmithKline (GSK)
In a report released yesterday, Matthew Weston from UBS maintained a Hold ratin...
09-18 11:15
GSK Halts Key Phase 2 Alzheimer’s Trial, Resetting Investor Expectations
GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. The...
09-18 00:30
IL-5靶点，进入收获期
（来源：药研网） 2026年6月23日，葛兰素史克宣布，国家药品监督管理局已批准美泊利珠单抗注射液（新可来®）用于成人和12岁及以上青少年无明确的非血液学继发性...
09-17 11:34
葛兰素史克以高达7.5亿美元收购中国生物技术公司药物
（来源：欧洲并购与投资） 葛兰素史克以高达7.5亿美元收购中国生物技术公司药物 图片来源于网络 英国制药集团GSK近日再次加码中国创新药，与中国生...
09-16 16:13
GSK与恩沐生物达成一项价值高达7.5亿美元的癌症靶向药物交易
9月15日，财闻据路透社报道，葛兰素史克（GSK.US）已达成一项价值最高达7.5亿美元的协议，从中国生物技术公司恩沐生物购买一款三特异性T细胞衔接器（TCE...
09-15 15:21
Why Is GSK Stock Gaining Monday?
On Monday, GSK plc (NYSE:GSK) stock is trading higher on highly positive clinical data from two separate lung cancer trials, demonstrating significant efficacy and survival benefits across different patient populations. Strong Survival Rates In Small Cell Lung Cancer In partnership with licensor Han...
09-15 00:03
派息除權日
|
每股總股息
| 派息日期 |
2026-08-14
|
0.44
|
2026-10-08
|
2026-05-15
|
0.45
|
2026-07-09
|
2026-02-20
|
0.48
|
2026-04-09
|
2025-11-14
|
0.41
|
2026-01-08
|
2025-08-15
|
0.42
|
2025-10-09
|
2025-05-16
|
0.42
|
2025-07-10
|
2025-02-21
|
0.39
|
2025-04-10
|
2024-11-15
|
0.38
|
2025-01-09
|
2024-08-16
|
0.38
|
2024-10-10
|
2024-05-16
|
0.37
|
2024-07-11
|
2024-02-22
|
0.40
|
2024-04-11
|
2023-11-16
|
0.33
|
2024-01-11
|
2023-08-17
|
0.35
|
2023-10-12
|
2023-05-18
|
0.34
|
2023-07-13
|
2023-02-23
|
0.33
|
2023-04-13
|
2022-11-17
|
0.31
|
2023-01-12
|
2022-08-18
|
0.38
|
2022-10-06
|
2022-05-19
|
0.34
|
2022-07-01
|
2022-02-24
|
0.61
|
2022-04-07
|
2021-11-18
|
0.52
|
2022-01-13
|
2021-08-19
|
0.52
|
2021-10-07
|
2021-05-20
|
0.52
|
2021-07-08
|
2021-02-18
|
0.62
|
2021-04-08
|
2020-11-12
|
0.49
|
2021-01-14
|
2020-08-13
|
0.48
|
2020-10-08
|
2020-05-14
|
0.46
|
2020-07-09
|
2020-02-20
|
0.59
|
2020-04-09
|
2019-11-14
|
0.48
|
2020-01-09
|
2019-08-08
|
0.46
|
2019-10-10
|
2019-05-16
|
0.47
|
2019-07-11
|
2019-02-21
|
0.59
|
2019-04-11
|
2018-11-15
|
0.48
|
2019-01-10
|
2018-08-09
|
0.49
|
2018-10-11
|
2018-05-10
|
0.50
|
2018-07-12
|
2018-02-22
|
0.65
|
2018-04-12
|
2017-11-09
|
0.51
|
2018-01-11
|
2017-08-09
|
0.50
|
2017-10-12
|
2017-05-10
|
0.49
|
2017-07-13
|
2017-02-22
|
0.57
|
2017-04-13
|
2016-11-02
|
0.46
|
2017-01-12
|
2016-08-10
|
0.46
|
2016-10-13
|
2016-05-11
|
0.50
|
2016-07-14
|
2016-02-17
|
1.22
|
2016-04-14
|
2015-11-10
|
0.54
|
2016-01-14
|
2015-08-12
|
0.57
|
2015-10-01
|
2015-05-13
|
0.58
|
2015-07-09
|
2015-02-18
|
0.70
|
2015-04-09
|
2014-11-05
|
0.61
|
2015-01-08
|
2014-08-06
|
0.65
|
2014-10-02
|
2014-05-14
|
0.64
|
2014-07-10
|
2014-02-19
|
0.75
|
2014-04-10
|
2013-11-13
|
0.62
|
2014-01-09
|
2013-08-07
|
0.55
|
2013-10-03
|
2013-05-08
|
0.55
|
2013-07-11
|
2013-02-20
|
0.69
|
2013-04-11
|
2012-11-14
|
0.58
|
2013-01-03
|
2012-08-08
|
0.53
|
2012-10-04
|
2012-05-09
|
0.55
|
2012-07-05
|
2012-02-15
|
0.82
|
2012-04-12
|
2011-11-02
|
0.54
|
2012-01-05
|
2011-08-03
|
0.52
|
2011-10-06
|
2011-05-04
|
0.53
|
2011-07-07
|
2011-02-09
|
0.62
|
2011-04-07
|
2010-10-27
|
0.51
|
2011-01-06
|
2010-07-28
|
0.46
|
2010-10-07
|
2010-05-05
|
0.46
|
2010-07-08
|
2010-02-10
|
0.57
|
2010-04-08
|
2009-11-04
|
0.49
|
2010-01-07
|
2009-07-29
|
0.46
|
2009-10-08
|
2009-04-29
|
0.41
|
2009-07-09
|
2009-02-11
|
0.49
|
2009-04-09
|
2008-10-29
|
0.47
|
2009-01-08
|
2008-07-30
|
0.52
|
2008-10-09
|
2008-04-30
|
0.52
|
2008-07-10
|
2008-02-13
|
0.63
|
2008-04-10
|
2007-10-31
|
0.53
|
2008-01-10
|
2007-08-01
|
0.49
|
2007-10-11
|
2007-05-02
|
0.48
|
2007-07-12
|
2007-02-14
|
0.55
|
2007-04-12
|
2006-11-01
|
0.45
|
2007-01-04
|
2006-08-02
|
0.41
|
2006-10-05
|
2006-05-10
|
0.39
|
2006-07-06
|
2006-02-15
|
0.49
|
2006-04-06
|
2005-11-02
|
0.36
|
2006-01-05
|
2005-08-03
|
0.35
|
2005-10-06
|
2005-05-11
|
0.38
|
2005-07-07
|
2005-02-16
|
0.44
|
2005-04-07
|
2004-11-03
|
0.37
|
2005-01-06
|
2004-08-04
|
0.37
|
2004-09-30
|
2004-05-12
|
0.35
|
2004-07-01
|
2004-02-18
|
0.52
|
2004-04-15
|
2003-10-29
|
0.30
|
2004-01-06
|
2003-07-30
|
0.29
|
2003-10-02
|
2003-05-07
|
0.29
|
2003-07-03
|
2003-02-19
|
0.42
|
2003-04-17
|
2002-10-30
|
0.28
|
2003-01-03
|
2002-07-31
|
0.28
|
2002-10-03
|
2002-05-01
|
0.26
|
2002-07-05
|
2002-02-20
|
0.34
|
2002-04-18
|
2001-10-31
|
0.26
|
2002-01-03
|
2001-08-01
|
0.25
|
2001-10-04
|
2001-05-02
|
0.26
|
2001-07-05
|
2000-12-27
|
0.66
|
2001-04-27
|
2000-08-09
|
0.43
|
2000-10-26
|
2000-03-01
|
0.65
|
2000-06-05
|
1999-08-11
|
0.49
|
1999-10-12
|
1999-03-03
|
0.68
|
1999-06-01
|
1998-08-12
|
0.51
|
1998-10-13
|
1998-03-04
|
0.65
|
1998-06-01
|
1997-08-13
|
0.48
|
1997-10-13
|
1997-03-19
|
0.50
|
1997-05-30
|
1996-08-16
|
0.50
|
1996-10-11
|
1996-03-22
|
0.48
|
1996-05-30
|
1995-09-22
|
0.67
|
1995-11-02
|
1995-02-24
|
0.34
|
1995-04-20
|
1994-09-23
|
0.60
|
1994-12-01
|
1994-03-14
|
0.28
|
1994-04-21
|
1993-09-24
|
0.47
|
1993-11-29
|
1993-03-05
|
0.23
|
1993-05-10
|
1992-09-21
|
0.38
|
1992-11-23
|
1992-02-28
|
0.24
|
1992-05-11
|
1982-05-12
|
0.09
|
1982-07-06
|
1981-11-20
|
0.16
|
1982-01-19
|
1981-05-18
|
0.08
|
1981-07-03
|
1980-11-21
|
0.17
|
1981-01-19
|
